会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • DRIVE MECHANISM FOR DRUG DELIVERY PUMPS WITH INTEGRATED STATUS INDICATION
    • 具有集成状态指示的药物输送泵的驱动机构
    • WO2015084428A1
    • 2015-06-11
    • PCT/US2014/032399
    • 2014-03-31
    • UNITRACT SYRINGE PTY LTDAGARD, Ryan M.
    • AGARD, Ryan M.HANSON, Ian B,CICCARELLI, Nicholas J.O'CONNOR, Sean M.BOKELMAN, KevinBENTE IV, Paul F.LOVE, John C.HATCH, Christopher Edward
    • A61M5/145A61M5/20
    • A61M5/2033A61M5/14566A61M2205/58
    • A drive mechanism 2100, 3100 includes a housing 2130, a piston 2110 adapted to impart movement to a plunger seal 2060 within a drug container 2050, a plurality of biasing members 2106, 2122 disposed in parallel, and a retainer 2115. The biasing members 2106, 2122 are disposed to release energy to cause movement of the piston 2110 from a retracted first position to the extended second position, the piston 2110 bearing against the plunger seal 2060 to dispense medicine. The retainer 2115 is disposed to maintain the biasing members 2106, 2122 in the energized position and to release the biasing members 2106, 2122 to permit the piston 2110 to dispense the medicine. The drive mechanism 2100, 3100 may also include an end-of-dose indicator 2133, 3133 to identify at least one of when the sleeve assembly 2120, 3120 is disposed subjacent a window 2131, 3131 in the housing 2130, 3130 the relative motion of the sleeve assembly 2120, 3120 with reference to the window 2131, 3131 or another reference component, the stoppage of such motion, and the rated or change of rate of motion.
    • 驱动机构2100,3100包括壳体2130,活塞2110,适于向药物容器2050内的柱塞密封件2060施加活动,多个平行设置的偏置构件2106,2122和保持器2115.偏置构件2106 ,2122被设置为释放能量以使活塞2110从缩回的第一位置移动到延伸的第二位置,活塞2110抵靠柱塞密封件2060以分配药物。 保持器2115设置成将偏置构件2106,22122保持在通电位置并且释放偏压构件2106,2122以允许活塞2110分配药物。 驱动机构2100,3100还可以包括剂量终止指示器2133,33133,以识别当套筒组件2120,31220设置在壳体2130内的窗口2131,33131的下方时,3130中的至少一个,3130的相对运动 套筒组件2120,31220参照窗口2131,33131或另一参考部件,停止这种运动以及运动速度的额定或改变。
    • 2. 发明申请
    • DRIVE MECHANISM FOR DRUG DELIVERY PUMPS WITH INTEGRATED STATUS INDICATION
    • 具有集成状态指示的药物输送泵的驱动机构
    • WO2014116987A1
    • 2014-07-31
    • PCT/US2014/013005
    • 2014-01-24
    • UNITRACT SYRINGE PTY LTDAGARD, Ryan M.
    • AGARD, Ryan M.HANSON, Ian B.CICCARELLI, Nicholas J.O'CONNOR, Sean M.BOKELMAN, KevinBENTE IV, Paul F.
    • A61M5/145
    • A61M5/1454A61M5/14566A61M2205/58
    • A drive mechanism 2100 includes a housing 2130, a piston 2110 adapted to impart movement to a plunger seal 2060 within a drug container 2050, a plurality of biasing members 2106, 2122 disposed in parallel, and a retainer 2115. The biasing members 2106, 2122 are disposed to release energy to cause movement of the piston 2110 from a retracted first position to the extended second position, the piston 2110 bearing against the plunger seal 2060 to dispense medicine. The retainer 2115 is disposed to maintain the biasing members 2106, 2122 in the energized position and to release the biasing members 2106, 2122 to permit the piston 2110 to dispense the medicine. The drive mechanism 2100 may also include an end-of-dose indicator 2133 to identify at least one of when the sleeve assembly 2120 is disposed subjacent a window 2131 in the housing 2130, the relative motion of the sleeve assembly 2120 with reference to the window 2131 or another reference component, the stoppage of such motion, and the rated or change of rate of motion.
    • 驱动机构2100包括壳体2130,活塞2110,其适于向药物容器2050内的柱塞密封件2060施加活动,多个平行设置的偏压构件2106,2212和保持器2115.偏置构件2106,2122 被设置为释放能量以使活塞2110从缩回的第一位置移动到延伸的第二位置,活塞2110抵靠柱塞密封件2060以分配药物。 保持器2115设置成将偏置构件2106,22122保持在通电位置并且释放偏压构件2106,2122以允许活塞2110分配药物。 驱动机构2100还可以包括剂量末端指示器2133,用于识别当套筒组件2120位于壳体2130内的窗口2131的下方时的至少一个,套筒组件2120参考窗口的相对运动 2131或其他参考组件,停止此类运动,以及运动速率的额定值或变化。
    • 6. 发明申请
    • FLUID RESTRICTION MECHANISMS FOR DRUG DELIVERY PUMPS
    • 用于药物输送泵的流体限制机构
    • WO2014116998A2
    • 2014-07-31
    • PCT/US2014/013019
    • 2014-01-24
    • UNITRACT SYRINGE PTY LTDO'CONNOR, Sean M.
    • O'CONNOR, Sean M.HANSON, Ian B.BENTE IV, Paul F.CLEMENTE, Matthew J.
    • A61M5/14
    • A61M5/16813A61M5/141A61M5/14248A61M5/1452A61M5/1454A61M5/16822A61M2205/13
    • A replaceable fluid restriction mechanism 500, 1500 includes: an aperture 520A residing adjacent to a fluid pathway connection and configured to permit flow of a drug fluid through the aperture 520A when the fluid pathway connection is open; an entry point 520B of a fluid channel 520C configured such that the flow of drug fluid can travel through aperture 520A to the entry point 520B and through the fluid channel 520C to an exit point 520D; and an outlet aperture 514 of a port 512 through which the flow of drug fluid may travel after exiting the exit point 520D, wherein a fluid conduit 30 is connected to the fluid restriction mechanism at the outlet aperture. A configurable fluid restriction mechanism 500, 1500 includes a plurality of fluid channels 520C, 521C, 522C, 523C, selectable to align with the entry point 520B and an exit point 520D of the fluid restriction mechanism.
    • 可替换的流体限制机构500,1500包括:邻近流体通路连接并且构造成允许药物流体在流体通路连接打开时通过孔520A流动的孔520A; 流体通道520C的入口点520B被配置为使得药物流体的流动可以通过孔520A行进到入口点520B并且通过流体通道520C行进到出口点520D; 以及端口512的出口孔514,药物流体的流动可以在离开出口点520D之后行进,其中流体导管30在出口孔处连接到流体限制机构。 可配置流体限制机构500,1500包括多个流体通道520C,521C,522C,523C,其可选择地与流体限制机构的入口点520B和出口点520D对准。
    • 9. 发明申请
    • DRIVE MECHANISM FOR DRUG DELIVERY PUMPS WITH INTEGRATED STATUS INDICATION
    • 具有综合状态指示的药物递送泵的驱动机构
    • WO2013033467A2
    • 2013-03-07
    • PCT/US2012/053241
    • 2012-08-30
    • UNITRACT SYRINGE PTY LTDO'CONNOR, Sean M.BOKELMAN, KevinHANSON, Ian B.BENTE IV, Paul F.
    • O'CONNOR, Sean M.BOKELMAN, KevinHANSON, Ian B.BENTE IV, Paul F.
    • A61M5/145
    • A61M5/172A61M5/1452A61M5/14566A61M2005/14506A61M2205/58
    • A drive mechanism (100) having integrated status indication includes a drive housing (130), a status switch interconnect (132), a drive biasing member (122), a piston (110), and a drug container (50) having a cap (52), a pierceable seal (56), a barrel (58), and a plunger seal (60), wherein the drive biasing member (122) is configured to bear upon an interface surface (110C) of the piston (110). Drive mechanism (100) may include an incremental status stem (650) having a stem interconnect (652), wherein the stem (650) resides within the drive housing (630) and the piston (610), and wherein the stem (650) has an interconnect which engages one or more contacts on the piston (610) to provide incremental feedback. A drug delivery pump (10) with integrated status indication includes a housing (12) and an assembly platform (20), upon which an activation mechanism (14), an insertion mechanism (200), a fluid pathway connection (300), a power and control system (400), and the drive mechanism (100) having a drug container (50) may be mounted.
    • 具有集成状态指示的驱动机构(100)包括驱动外壳(130),状态开关互连(132),驱动偏置构件(122),活塞(110)和 (52),可刺穿的密封件(56),筒(58)和柱塞密封件(60)的药物容器(50),其中所述驱动偏置构件(122)构造成承载界面表面 110C)。 驱动机构100可以包括具有阀杆互连652的增量状态阀杆650,其中阀杆650位于驱动器壳体630和活塞610内, 具有接合活塞(610)上的一个或多个触点以提供增量反馈的互连。 具有集成状态指示的药物输送泵(10)包括壳体(12)和组装平台(20),在该组装平台上设置有激活机构(14),插入机构(200),流体路径连接(300), 动力和控制系统(400)以及具有药物容器(50)的驱动机构(100)可以被安装。